Search

Author/Creator Lucas, Nisha

2. Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis. Issue 7 (July 2016)

Authors:
Krueger, James; Kircik, Leon; Hougeir, Firas; Friedman, Adam; You, Xiaojun; Lucas, Nisha; Greenberg, Steven; Sweetser, Marianne; Castro-Borrero, Wanda; McCroskery, Peter; Elkins, Jacob
Journal:
Advances in therapy
Issue:
Volume 33:Issue 7(2016)
Page Start:
1231
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. Issue 5 (May 2018)

Authors:
Kapoor, Raju; Ho, Pei-Ran; Campbell, Nolan; Chang, Ih; Deykin, Aaron; Forrestal, Fiona; Lucas, Nisha; Yu, Bei; Arnold, Douglas L; Freedman, Mark S; Goldman, Myla D; Hartung, Hans-Peter; Havrdová, Eva Kubala; Jeffery, Douglas; Miller, Aaron; Sellebjerg, Finn; Cadavid, Diego; Mikol, Dan; Steiner, D...
Journal:
Lancet neurology
Issue:
Volume 17:Issue 5(2018)
Page Start:
405
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗